H ypertension is the single most commonly treated chronic disease. Left untreated or undertreated, hypertension predisposes to heart disease, kidney failure, and stroke. In only half of those affected is blood pressure controlled. 1 A clearer understanding of why certain individuals become hypertensive could lead to more specific and effective therapies. The origins of hypertension are complex, but a feature common to virtually all forms is a pressure-natriuresis relationship that achieves a balance between intake and output of Na ϩ . 2, 3 Although a sustained increase in the kidney's reabsorption of Na ϩ underlies much of the need to generate a higher natriuretic pressure, 2 the specific nephron regions where the more active uptake occurs are not known. In the discussion that follows, we review findings from human studies that suggest that variations in Na ϩ uptake by the thick ascending limb (TAL) of the loop of Henle influence an individual's chronic level of blood pressure, as well as risk for hypertension. The intent of this review is to encourage consideration of TAL in the scheme of renal events that can affect blood pressure and influence a propensity for becoming hypertensive.
Regulation of TAL Function, Normally and in Bartter Syndrome
Approximately one quarter of the filtered load of Na ϩ is taken up in TAL, in part by way of the paracellular route (along an electric gradient) and in part by the Na
Ϫ cotransporter (NKCC2) residing at the apical surface (Figure) 4 (where uptake is electroneutral). One can begin to appreciate the complexity of its regulation from the number of genes that, when mutated, result in Bartter syndrome, a severe salt-losing nephropathy accompanied by low blood pressure 5 attributed to a functional deficiency in NKCC2. Lifton and others 6 showed that Bartter syndrome results from mutations in NKCC2 itself (type 1) or in its regulators [7] [8] [9] for a total of 5 types.
Loss-of-function mutations in KCNJ1, which encodes for the K ϩ channel renal outer medullary K ϩ (ROMK), result in Bartter syndrome type 2. 8 Because the tubular concentration of K ϩ in TAL is low relative to the concentrations of Na ϩ and Cl Ϫ , the availability of K ϩ for occupancy on the cotransporter is rate limiting for its activation. On the other hand, when recycling of K ϩ is impeded, Na ϩ uptake in TAL declines (an increase in K ϩ recycling would increase Na ϩ uptake). In addition, K ϩ returning to the lumen via ROMK results in a more positively charged milieu that promotes the departure of Ca ϩϩ and Mg ϩϩ through paracellular routes. Thus, as NKCC2 becomes more active, urinary excretion of these cations decreases. When NKCC2 activity is decreased as in the Bartter syndrome, Ca ϩϩ excretion is increased. 5 
Cl
Ϫ carried into the cell by NKCC2 exits through the Cl Ϫ channels CLCNKA and CLCNKB with facilitation by BSND (Bartter syndrome, infantile, with sensorineural deafness). Mutations in CLCNKB 7 and BSND 10 result in, respectively, types 3 and 4 Bartter syndrome. Thus, clearing the cell of the additional Cl Ϫ is a determinant of NKCC2 functional activity and potentially level of blood pressure.
The Ca ϩϩ sensing receptor (CASR) 11 on the basolateral surface in TAL 12 on binding Ca ϩϩ leads to inhibition of NKCC2. 12 This then results in a more negatively charged lumen (there is less recycling of K ϩ ), which facilitates excretion of Ca ϩϩ , serving as a means for correcting or preventing a state of hypercalcemia. CASR is also expressed in other sites in kidney 13 and in nonrenal sites including the parathyroid gland, where a gain-of-function mutation in CASR can result in not only Bartter syndrome (type 5) but also hypoparathyroidism. 9 The scope of the regulation of TAL activities, however, goes much beyond what can be appreciated from studying Bartter syndrome. For example, TAL function is highly integrated into the dynamic events of the renal medulla, where regulation is multifaceted. NO, which inhibits NKCC2, is a principal conveyor of influence here, as demonstrated in a series of studies. 14 -16 Other bioactive mediators include endothelin, 15 superoxide, 17 angiotensin II, 18 vasopressin, 19 and prostaglandins. 20 An excellent and comprehensive review of the renal medulla and blood pressure by Cowley was published in Hypertension in 2008. 21 
Race Differences in TAL Function?
The existence of a more actively functioning TAL in large population groups is suggested from studies comparing blacks with whites. Hypertension in blacks is more common 22 and clinically a more serious disorder 23 than in whites. Blood pressure in blacks is typically salt sensitive, which differs from what is observed in whites. 24, 25 In children, long before hypertension is likely to occur, and maybe in part why its onset is delayed, plasma aldosterone levels and aldosterone excretion rates are lower in blacks than in whites. 26 The reduced aldosterone levels were shown to result in less Na ϩ reabsorption by the epithelial Na ϩ channel (ENaC), as evidenced by an effect of amiloride, an inhibitor of ENaC, to lower blood pressure significantly in whites in comparison with blacks. 27 An increase in Na ϩ reabsorption that led to a suppressed renin-angiotensin-aldosterone system seemed to take place upstream in the nephron. A likely site was TAL because an increase in its function would predictably resemble what is observed in blacks, including lower levels of plasma renin activity and aldosterone and lower urinary excretion rates of K ϩ and Ca ϩϩ (Table 1) .
Differences in Electrolyte Excretion
Racial differences in TAL function can be suggested from excretion rates of certain cations. Although urinary excretion rates of Na ϩ are similar in blacks and whites, 26 35 made similar observations in adolescent girls studied under highly controlled and carefully monitored inpatient conditions. They also measured fecal and sweat K ϩ but could not detect a race difference in their excretion. Thus, although in blacks dietary intake of K ϩ appears to be definitely less than that for whites, the lower urinary excretion rates of K ϩ in blacks may also reflect a difference in K ϩ handling. Race differences in the kidney disposition of K ϩ can be appreciated more easily by observing the kinetics of K ϩ . Luft et al 36 studied responses to graded increments in Na ϩ intake (10 to 1500 mmol/d) in blacks and in whites and where K ϩ intake was set at 80 mmol/d. At the lower intakes of Na ϩ , there was a net accumulation of K ϩ in both race groups-the maximal amount reached was Ϸ200 mmol in blacks and 100 mmol in whites. As the intake of Na ϩ reached higher levels, a kaliuresis ensued (earlier in whites than in blacks). At the highest intake of Na ϩ , the net loss of K ϩ was in the range of 400 mmol in whites and Ͻ100 mmol in blacks. Thus, over a wide range of Na ϩ intakes, the fractional excretion of K ϩ was consistently less in blacks. One explanation would be greater K ϩ uptake by NKCC2. A concurrently enhanced uptake of Na ϩ would result in less aldosterone targeting ENaC, leading to even less K ϩ secretion. K ϩ is a stimulus of aldosterone secretion, and reduced secretion rates in blacks could result from or be significantly influenced by a diet containing less K ϩ . Urinary excretion rates of aldosterone can be adjusted for dietary K ϩ by measuring K ϩ excretion over the same collection period if urinary K ϩ reflects dietary K ϩ . In a study of 351 white and 170 black children with multiple overnight urine collections (on average, 5 per subject at intervals of 6 months), K ϩ excretion accounted for 20% of the variation in aldosterone excretion (Na ϩ excretion accounted for 10%). After adjusting for urinary excretion of K ϩ and Na ϩ , the aldosterone excretion rate remained lower in blacks than in whites (35% lower; PϽ0.0001). 37 Plasma aldosterone levels cannot be adjusted as easily for variations in diet, but the lower levels of aldosterone would be expected to at least partially result from less stimulation by angiotensin II (levels of plasma renin activity being lower), with less of an effect of angiotensin II and K ϩ to stimulate synergistically. 38, 39 TAL is a principal site for reclaiming the divalent cations, Ca ϩϩ and Mg ϩϩ . 40 -42 A more active NKCC2 would render the tubular lumen more positively charged, thereby favoring their paracellular uptake. Blacks have been shown repeatedly to have lower urinary excretion rates of Ca ϩϩ than whites [43] [44] [45] ; Mg ϩϩ excretion rates are also lower in blacks. 32 The race difference in Ca ϩϩ excretion remains when dietary Ca ϩϩ is kept constant in the 2 groups, 44, 45 and gastrointestinal absorption of Ca ϩϩ is actually higher in blacks than in whites. 46 Although not the only site for Ca ϩϩ and Mg ϩϩ reabsorption, their lower excretion rates at the least suggest a higher level of NKCC2 activity in TAL.
Differences in Water Conservation
Blacks have a more recent ancestral history of living in sub-Saharan desert regions where a highly developed ability to reclaim Na ϩ was life sustaining. Bankir et al 47 has suggested that a climatic adaptation even more relevant to survival was a means for conserving water in that survival is placed in jeopardy more quickly in the absence of water than in the absence of salt. Using data collected in earlier clinical studies, Bankir and her collaborators 47, 48 showed that blacks indeed concentrate urine to a greater extent than whites. Higher levels of vasopressin in blacks that could account for the race difference have been observed, but only in blacks who were hypertensive, 49 -51 and not in blacks who were normotensive, 32,50 even when challenged with water deprivation. 52 If not vasopressin dependent, the possibility remains that the renal medullary osmotic gradient that water in the collecting duct is reabsorbed against is greater in blacks. The gradient is partially a product of TAL activity in that Na ϩ reabsorbed here adds to the osmotic differential that draws water from the collecting duct; thus, one explanation for the more concentrated urine in blacks could be a more active TAL. For blacks to maintain a state of greater water conservation by this mechanism, vasopressin secretion must not fully "adjust" (secondarily decrease), which indeed may be the case, since lower levels of vasopressin have not been described in blacks.
Differences in Response to Acute Perturbations of TAL Function
A role for TAL in determining race differences in water conservation and urinary excretion of cations was studied by comparing the response in blacks and whites to complete inhibition of NKCC2 with a single dose of furosemide, 40 mg IV. 32 At baseline and with ad libitum intake of water, urine concentrations and volumes were lower in blacks, but when water intake was restricted to a constant intravenous infusion, the race difference in water conservation disappeared. The baseline race differences in urinary excretion of K ϩ (44% lower in blacks) and Ca ϩϩ (22% lower in blacks) were reduced by half in response to inhibition of NKCC2. Although a clear delineation of a mechanism for why blacks conserve water better than whites could not be determined with certainty, changes in cation excretion in response to furosemide were consistent with there being greater TAL activity in blacks.
Weder et al 53 used a water-loading protocol to assess free water generation in cortical TAL, as well as distal convoluted tubule. These nephron regions are impermeable to water, and the tubular fluid becomes increasingly dilute because of removal of ions by NKCC2. The water loading suppresses the levels of endogenous vasopressin, and the final urine concentration is a gauge of the reabsorption of ions by NKCC2. Under these conditions, blacks produced a less dilute urine than whites, consistent with their having a lower level of NKCC2 activity in cortical TAL. The greater uptake of Na ϩ in medullary TAL (suggested by furosemide study) and reduced uptake in cortical TAL (revealed in water-loading study) would be complimentary for purposes of optimizing water conservation.
Increased NKCC2 Activity and a Decrease in Tubuloglomerular Feedback: A Proposed Mechanism for Salt-Sensitive Hypertension in Blacks
Aviv et al 54, 55 undertook a review of previously reported clinical studies, which then led them to place TAL, at least theoretically, in a pivotal position for contributing to the heightened susceptibility of blacks to hypertension. A mechanism whereby an increase in NKCC2 activity leads to an expansion of the extracellular volume or an alternative mechanism whereby no expansion occurs was proposed. Either would result in a decrease in urinary K ϩ excretion and increased Na ϩ reabsorption and greater water conservation. An increase in Na ϩ uptake by NKCC2 would enhance tubuloglomerular feedback (less Na ϩ reaching the macula densa) leading to glomerular hyperfiltration (by reducing afferent arteriolar tone) and, in turn, the delivery of more Na ϩ to the proximal tubule, resulting in an increase in the absolute amount of Na ϩ reabsorbed here and downstream in TAL. Glomerular hyperfiltration would also result in an increase in colloidal osmotic pressure in the peritubular arterioles to further promote Na ϩ reabsorption. Of course an increase in NKCC2 activity that increased blood pressure would be met by an adjustment consisting of reduced Na ϩ reabsorption in the proximal tubule, and suppression of the renin-angiotensinaldosterone system would further help to restore Na ϩ balance. Bochud et al 56 used the clearance of endogenous Li ϩ to estimate Na ϩ reabsorption in proximal and downstream nephron segments. They showed, first of all, that reabsorption was heritable. In addition, proximal reabsorption was found to be greater in South African blacks than in Belgian whites. The evidence for greater proximal tubular reabsorption of Na ϩ in blacks could be explained by a more active TAL, resulting in less tubuloglomerular feedback, followed by greater glomerular filtration with delivery of more Na ϩ to the proximal tubule that then increases absolute amounts of Na ϩ reabsorption, as was proposed by Aviv et al. 54 
Shortcomings of Clinical Studies
A role for TAL in regulating blood pressure in humans is difficult to establish due in part to limitations inherent to clinical assessments. In the case where TAL function was increased, the increment in retained Na ϩ required to raise blood pressure would probably be small, only enough over time to supersede any adjustments occurring elsewhere, either proximally or distally. In the case of the latter, for example, ENaC in the collecting duct reabsorbs only a small fraction, possibly as little as 2%, of the filtered load of Na ϩ . Any increase in Na ϩ reabsorption in TAL would need only to exceed this small fractional range to potentially affect blood pressure. If one could directly probe the function of NKCC2, which one cannot, the level of activity that was enough to result in Na ϩ retention and an increase in blood pressure might not be detectable. On the other hand, a sustained effect that resulted in a chronically developed state might easily be recognized. This could take the form, in the case of a more active TAL, of a higher urine concentration or higher blood pressure.
Recent advances in imaging the human kidney hold promise for intrarenal quantitative measurements. 23Na MRI was used by Maril et al 57 to determine the contribution of NKCC2 to the renal medullary osmotic gradient. Using this noninvasive approach, these investigators demonstrated that water deprivation resulted in a 25% increase in the gradient within 12 hours. Conceivably, such techniques could delineate race differences both basally and after certain manipulations, such as the administration of furosemide.
Genetic Studies
The genetically derived Dahl salt-sensitive rat and Milan rat, widely used models of hypertension, have a more active TAL than their respective controls. 20, 58, 59 For the rare mendelian forms of hypertension, the single gene mutations in every instance localize the increase in Na ϩ reabsorption to either the collecting duct 60, 61 or the distal convoluted tubule, 62 but never to TAL. The only known monogenic blood pressure disorders of which expression takes place in TAL results in hypotension (collectively, Bartter syndrome), thus suggesting a role for variations in TAL to lower rather than raise blood pressure, to mitigate risk rather than increase risk for hypertension. A search for rare genetic variants is currently considered a promising means for delineating genetic contributions to complex diseases. 63 When members of the Framingham Heart Study were screened for rare mutations in 2 genes, SLC12A1 (NKCC2) and KCNJ1 (ROMK), which, in the homozygous state, produce Bartter syndrome, significant associations of these mutations in the heterozygous state with a lower blood pressure were observed. 64 In a second study, common variants in KCNJ1 were also shown to associate with a lower blood pressure. 65 These studies limited to these 2 genes together with the severe loss of function in Bartter syndrome imply a role of TAL variants to diminish the likelihood for hypertension.
An association study with common variants of CASR showed a significantly positive association with both blood pressure and urinary Ca ϩϩ excretion in blacks but not in whites. 66 In a recent genome-wide meta-analysis (data integrated from separate cohorts of whites and Indian Asians), 67 serum Ca ϩϩ concentration associated with single nucleotide polymorphisms in and around CASR (Pϭ6ϫ10 Ϫ37 for the most significant single nucleotide polymorphism), demonstrating that common variations in the receptor may indeed affect function. Illustrating the extent to which CASR can influence Na ϩ homeostasis, Ca ϩϩ infused into healthy men, raising serum Ca ϩϩ levels by 25%, seemingly enough to increase binding of Ca ϩϩ to CASR and inhibit NKCC2, 12 increasing excretion of Na ϩ by 150%. 68 Although it was reported early on that diets higher in Ca ϩϩ were accompanied by lower blood pressures, 69 subsequent studies demonstrated little if any clinically significant improvement in blood pressure after enrichment of diets with Ca ϩϩ . 70, 71 To our knowledge, however, an effect of dietary Ca ϩϩ on blood pressure has not been studied extensively in blacks, a population group that could, if enhanced natriuresis is mechanistically involved, be more responsive to dietary manipulations of Ca ϩϩ .
CYP450 Enzymes and 20-Hydroxyeicosatetraenoic Acid
In animal models of hypertension, 20-hydroxyeicosatetraenoic acid (20-HETE) can lower blood pressure by inhibiting NKCC2. 72 The Dahl salt-sensitive rat, for example, may have increased NKCC2 activity at least in part because of reduced levels of 20-HETE. 20, 73 Salt-sensitive human hypertension has been associated with a decrease in urinary excretion of 20-HETE after furosemide administration, 74 suggesting that a 20-HETE deficiency state with less inhibition of NKCC2 contributes to salt sensitivity of blood pressure. 20-HETE is synthesized from arachidonic acid by cytochrome CYP450 enzymes 75 (specifically, the CYP 4A and 4F families of enzymes synthesize 20-HETE). A variant nucleotide in the gene for CYP4A11, T8590C, which has known reduced catalytic activity, was found to associate with hypertension in subjects from 2 independent population groups. 76 Additional studies have also now found significant associations with T8590C. 77, 78 Hypertensive blacks from the African American Study of Kidney Disease (AASKD) showed an association of the 8590CC genotype with a higher systolic blood pressure. 79 20-HETE also increases vascular tone and can potentially raise blood pressure. 80 A variant in CYP4F2, an additional enzyme for 20-HETE synthesis, was associated with increases in both 20-HETE and blood pressure, 81 demonstrating the less than always straightforward effects of 20-HETE on blood pressure. The genetic variation in the enzymes that lead to different levels of 20-HETE would seem to be extremely promising determinants of hypertension risk. There is a strong likelihood that much of their blood pressure effects are mediated through ion transport in TAL. Association studies with candidate genes can potentially identify, for example, variations in ion transport systems that alter Na ϩ reabsorption to where blood pressure is affected.
There are important limitations imposed by the complexity of the phenotype and also by the fact that genes expressed in TAL may also be expressed in other regions of the kidney or even outside the kidney where they have potential to affect blood pressure. Despite these shortcomings, genetic approaches may be the best (maybe the only) means to provide confirmation of a role for Na ϩ uptake in TAL to affect blood pressure. Table 2 summarizes the reported associations of gene variants that encode for proteins affecting Na ϩ uptake in TAL.
Dependency of TAL on Other Nephron Regions to Affect Blood Pressure
Before Na ϩ reabsorption in TAL can reach a level sufficient to raise blood pressure it may need "assistance" from another kidney site. When, for example, Na ϩ reabsorption by NKCC2 is increased, the distal nephron, primarily ENaC in the collecting duct, should, in response to the renin-angiotensinaldosterone system, reduce its uptake of Na ϩ accordingly. Should this corrective action fall short, a higher blood pressure could ensue. The distal nephron may not fully adapt to upstream uptake of Na ϩ because of an intrinsically more active ENaC or to an elevated level of aldosterone. [82] [83] [84] Indeed, it was shown recently that activation of the Na ϩ -Cl Ϫ cotransporter required participation by ENaC or another Na ϩ reabsorption site. 85 Variations in proximal tubular function could also take part in establishing the arterial pressure necessary to achieve the natriuresis for maintaining Na ϩ balance. 86 When searching for a role for TAL to increase blood pressure, one might miss it unless one also considers the distal nephron or proximal tubule. At the same time, greater Na ϩ reabsorption elsewhere could require a more active TAL before manifesting in an increase in blood pressure.
Perspectives
TAL has been shown to be a site for a variety of monogenic forms of hypotension, collectively known as Bartter syndrome. Variations in Na ϩ uptake in TAL hold the potential to similarly influence Na ϩ reabsorption and, in turn, blood pressure. A comparison of race groups suggests that TAL can also operate at a higher level in blacks, a population group prone to develop a more severe type of hypertension. Clinical studies of TAL might be best served by inclusion of blacks. Future studies should encompass additional translational research, applying what has been learned from animal models to studies of clinical hypertension and vice versa. For example, generation of models that incorporate functional variants of CASR in TAL to look for blood pressure responses to differences in dietary calcium. Knowing that TAL participated in the development of hypertension more commonly than currently realized could have a practical bearing, by providing, for example, the impetus for designing loop diuretics that are more lifestyle compatible or by making possible the selection of certain groups based on genotype and race who would benefit from diets enriched in Ca ϩϩ . If TAL is shown to participate in affecting hypertension risk (either by lowering it or increasing it), preventive strategies and treatment paradigms for many individuals could change.
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